Morgan Stanley 13D and 13G filings for Taysha Gene Therapies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-05 10:43 am Purchase | 2024-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA | MORGAN STANLEY MS | 17,629,264 8.600% | 17,629,264 (New Position) | Filing |